Quest Diagnostics Incorporated (DGX) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Secaucus, NJ, United States. Le PDG actuel est James E. Davis.
DGX a date d'introduction en bourse 1996-12-17, 55,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $21.49B.
Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and services operating in the United States and internationally. The company delivers a comprehensive range of clinical laboratory services, including routine testing, advanced clinical testing, and anatomic pathology testing, serving patients, clinicians, hospitals, health plans, and employers through an extensive network of laboratories and patient service centers. Quest Diagnostics operates multiple diagnostic brands including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, while also offering risk assessment services for the life insurance industry and healthcare information technology solutions to support clinical operations. Founded in 1967 and headquartered in Secaucus, New Jersey, the company leverages a diverse workforce of phlebotomists, nurses, and health professionals to deliver diagnostic information across multiple service channels.
